Q fever: A biological weapon in your backyard

Lancet Infectious Diseases

Volumn 3, Issue 11, 2003, Pages 709-721

  Madariaga, Miguel G ^a,b   Rezai, Katayoun ^a   Trenholme, Gordon M ^a   Weinstein, Robert A ^a  

^a Jr Hospital of Cook County   (United States)

^b Division of Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; COXIELLA BURNETII VACCINE; DOXYCYCLINE; ERYTHROMYCIN; HYDROXYCHLOROQUINE; IND 610; LINCOMYCIN; MACROLIDE; OFLOXACIN; PEFLOXACIN; PREDNISONE; Q VAX; QUINOLONE DERIVATIVE; RIFAMPICIN; ROXITHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VACCINE;

AEROSOL; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BIOLOGICAL WARFARE; CHEMOPROPHYLAXIS; CHRONIC FATIGUE SYNDROME; COXIELLA BURNETII; DIAGNOSTIC APPROACH ROUTE; DISABILITY; EDEMA; ENDOCARDITIS; ERYTHEMA; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION SITE; LIVESTOCK; MORTALITY; NONHUMAN; PRIORITY JOURNAL; Q FEVER; REVIEW; SIDE EFFECT; VACCINATION;

EID: 0242386554     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00804-1     Document Type: Review

References (149)

1. Derrick EH. Q fever, a new entity: clinical features, diagnosis and laboratory investigation. Med J Aust 1937; 2: 281-99.
2. Quintal D. Historical aspects of the rickettsioses. Clin Dermatol 1996; 14: 237-42.
3. Cox HR. Cultivation of rickettsiae of the Rocky Mountain spotted fever, typhus and Q fever groups in embryonic tissues of developing chickens. Science 1941; 94: 399-403.
4. Doherty R. Australia's contribution to tropical health: past and present. Med J Aust 1993; 158: 552-57.
5. Burnet M. Derrick and the story of Q fever. Med J Aust 1967; 2: 1067-68.
6. Norlander L. Q fever epidemiology and pathogenesis. Microbes Infect 2000; 2: 417-24.
7. Anon. Biological warfare agents. http://www.acq.osd.mil/cp/cbdprimer_oct2001.pdf (accessed Sept 21, 2003).
8. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8: 225-30.
9. Kortepeter M, Cristopher G, Cieslak T, et al. USAMRIID's medical management of biological casualties handbook. Frederick, Maryland: US Army Medical Research, 2001: 33-36.
10. Khan AS, Swerdlow DL, Juranek DD. Precautions against biological and chemical terrorism directed at food and water supplies. Public Health Rep 2001; 116: 3-14.
11. Alexander DA. Bioterrorism: preparing for the unthinkable. J R Army Med Corps 2003; 149: 125-30.
12. Spicer AJ. Military significance of Q fever: a review. J R Soc Med 1978; 71: 762-67.
13. Moe JB, Pedersen CE Jr. The impact of rickettsial diseases on military operations. Mil Med 1980; 145: 780-85.
14. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278: 399-411.
15. Bellamy RJ, Freedman AR. Bioterrorism. QJM 2001; 94: 227-34.
16. Cekanac R, Lukac V, Coveljic M. An epidemic of Q fever in a unit of the Yugoslav Army during war conditions. Vojnosanit Pregl 2002; 59: 157-60.
17. Noah DL, Huebner KD, Darling RG, Waeckerle JF. The history and threat of biological warfare and terrorism. Emerg Med Clin North Am 2002; 20: 255-71.
18. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM Jr. Biological warfare: a historical perspective. JAMA 1997; 278: 412-17.
19. Alibek K. Biohazard. New York, NY: Random House, 1999: 29-38.
20. Winner SJ, Eglin RP, Moore VI, Mayon-White RT. An outbreak of Q fever affecting postal workers in Oxfordshire. J Infect 1987; 14:255-61.
21. Anon. Update: investigation of bioterrorism -related anthrax and adverse events from antimicrobial prophylaxis. MMWR Morb Mortal Wkly Rep 2001; 50: 973-76.
22. Aitken ID, Bogel K, Cracea E, et al. Q fever in Europe: current aspects of aetiology, epidemiology, human infection, diagnosis and therapy. Infection 1987; 15: 323-27.
23. Hilbink F, Penrose M, Kovacova E, Kazar J. Q fever is absent from New Zealand. Int J Epidemiol 1993; 22: 945-49.
24. Kimbrough RC 3rd, Ormsbee RA, et al. Q fever endocarditis in the United States. Ann Intern Med 1979; 91: 400-02.
25. Wagstaff DJ, Janney JH, Crawford KL, Dimijian GG, Joseph JM. Q fever studies in Maryland. Public Health Rep 1965; 80: 1095-99.
26. Anon. Q fever among slaughterhouse workers: California. MMWR Morb Mortal Wkly Rep 1986; 35: 223-26.
27. Reed CF, Schnurrenberger PR. Q fever surveillance in Ohio. Am J Epidemiol 1966; 84: 234-40.
28. Millis NS, Kuhnley LC. Evidence for the existence of Q fever in Northwest Texas. Am J Public Health 1978; 68: 590-92.
29. Wisniewski HJ, Krumbiegel ER. Q fever in the Milwaukee area, I: Q fever in Milwaukee area cattle. Arch Environ Health 1970; 21: 58-62.
30. Wisniewski HJ, Krumbiegel ER. Q fever in the Milwaukee area, 3: epidemiological studies of Q fever in humans. Arch Environ Health 1970; 21: 66-70.
31. Gross PA, Portnoy B, Salvatore MA, et al. Q fever in Los Angeles County. Serological survey of human and bovine populations. Calif Med 1971; 114: 12-15.
32. Ferris DH, Birge JP, Morrissey A, et al. Epidemiologic investigations of Q fever in a major milkshed region of the United States of America 1. J Hyg Epidemiol Microbiol Immunol 1973; 17: 375-84.
33. Ross C, Morrow PS. Q fever: an issue in occupational health and safety? An overview of the methods of control and the effects of Coxiella burnetii on the human host. J R Soc Health 1994; 114: 151-52.
34. Sienko DG, Bartlett PC, McGee HB, Wentworth BB, Herndon JL, Hall WN. Q fever: a call to heighten our index of suspicion. Arch Intern Med 1988; 148: 609-12.
35. Hall CJ, Richmond SJ, Caul EO, Pearce NH, Silver IA. Laboratory outbreak of Q fever acquired from sheep. Lancet 1982; 1: 1004-06.
36. Harrison RJ, Vugia DJ, Ascher MS. Occupational health guidelines for control of Q fever in sheep research. Ann N Y Acad Sci 1990; 590: 283-90.
37. Bayer RA. Q fever as an occupational illness at the National Institutes of Health. Public Health Rep 1982; 97: 58-60.
38. Johnson JE, Kadull PJ. Laboratory-acquired Q fever: a report of fifty cases. Am J Med 1966; 41: 391-403.
39. Fournier PE, Etienne J, Harle JR, Habib G, Raoult D. Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin Infect Dis 2001; 32: 1440-47.
40. Baca OG, Paretsky D. Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev 1983; 47: 127-49.
41. McQuiston JH, Childs JE. Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis 2002; 2: 179-91.
42. Hellenbrand W, Breuer T, Petersen L. Changing epidemiology of Q fever in Germany, 1947-1999. Emerg Infect Dis 2001; 7: 789-96.
43. Richardus JH, Donkers A, Dumas AM, et al. Q fever in the Netherlands: a sero-epidemiological survey among human population groups from 1968 to 1983. Epidemiol Infect 1987; 98: 211-19.
44. Sobradillo V, Ansola P, Baranda F, Corral C. Q fever pneumonia: a review of 164 community-acquired cases in the Basque country. Eur Respir J 1989; 2: 263-66.
45. Caron F, Meurice JC, Ingrand P, et al. Acute Q fever pneumonia: a review of 80 hospitalized patients. Chest 1998; 114: 808-13.
46. Aitken ID. Clinical aspects and prevention of Q fever in animals. Eur J Epidemiol 1989; 5: 420-24.
47. Raoult D, Marrie T. Q fever. Clin Infect Dis 1995; 20: 489-95.
48. Marrie TJ. Coxiella burnetii (Q fever) pneumonia. Clin Infect Dis 1995; 21 (suppl 3): S253-64.
49. Ayres JG, Smith EG, Flint N. Protracted fatigue and debility after acute Q fever. Lancet 1996; 347: 978-79.
50. Jorm LR, Lightfoot NF, Morgan KL. An epidemiological study of an outbreak of Q fever in a secondary school. Epidemiol Infect 1990; 104: 467-77.
51. Krumbiegel ER, Wisniewski HJ. Q fever in the Milwaukee area, 11: consumption of infected raw milk by human volunteers. Arch Environ Health 1970; 21: 63-65.
52. Behymer D, Riemann HP. Coxiella burnetii infection (Q fever). J Am Vet Med Assoc 1989; 194: 764-67.
53. Milazzo A, Hall R, Storm PA, Harris RJ, Winslow W, Marmion BP. Sexually transmitted Q fever. Clin Infect Dis 2001; 33: 399-402.
54. Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 2002; 162: 701-04.
55. Mann JS, Douglas JG, Inglis JM, Leitch AG. Q fever: person to person transmission within a family. Thorax 1986; 41: 974-75.
56. Weber DJ, Rutala WA. Risks and prevention of nosocomial transmission ofrare zoonotic diseases. Clin Infect Dis 2001; 32: 446-56.
57. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001; 285: 2763-73.
58. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287: 2236-52.
59. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management: working Group on Civilian Biodefense. JAMA 2000; 283: 2281-90.
60. Moran GJ. Threats in bioterrorism, II: CDC category B and C agents. Emerg Med Clin North Am 2002; 20: 311-30
61. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001; 33: 312-16.
62. Holloway HC, Norwood AE, Fullerton CS, Engel CC Jr, Ursano RJ. The threat of biological weapons: prophylaxis and mitigation of psychological and social consequences. JAMA 1997; 278: 425-27.
63. Noah DL, Noah DL, Crowder HR. Biological terrorism against animals and humans: a brief review and primer for action. J Am Vet Med Assoc 2002; 221: 40-43.
64. Paretsky D. The biology of Coxielia burnetti and the pathobiochemistry of Q fever and its endotoxicosis. Ann N Y Acad Sci 1990; 590: 416-21.
65. National Center for Biotechnology Information: Taxonomy browser. Bethesda, MD: NCBI, August 2003. http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi (accessed Sept 21, 2003).
66. Brouqui P, Dupont HT, Drancourt M, et al. Chronic Q fever: ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med 1993; 153: 642-48.
67. Raoult D, Levy PY, Harle JR, et al. Chronic Q fever: diagnosis and follow-up. Ann N Y Acad Sci 1990; 590: 51-60.
68. Hackstadt T. The role of lipopolysaccharides in the virulence of Coxiella burnetii. Ann N Y Acad Sci 1990; 590: 27-32.
69. Hackstadt T, Williams JC. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci USA 1981; 78: 3240-44.
70. Stein A, Raoult D. Q fever endocarditis. Eur Heart J 1995; 16 (suppl B): 19-23.
71. Raoult D. Host factors in the severity of Q fever. Ann N Y Acad Sci 1990; 590: 33-38.
72. Fiset P. Phase variation of Rickettsia (Coxiella) burnetii: study of the antibody response in guinea pigs and rabbits. Can J Microbiol 1957; 3: 435-45.
73. Peacock MG, Philip RN, Williams JC, Faulkner RS. Serological evaluation of Q fever in humans: enhanced phase 1 titres of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun 1983; 41: 1089-98.
74. Heinzen RA, Hackstadt T, Samuel JE. Developmental biology of Coxiella burnertii. Trends Microbiol 1999; 7: 149-54.
75. Heinzen RA, Hackstadt T. A developmental stage-specific histone H1 homolog of Coxiella burnetii. J Bacteriol 1996; 178: 5049-52.
76. McCaul TF, Williams JC. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 1981; 147: 1063-76.
77. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol 1998; 36: 1823-34.
78. Marrie TJ, Stein A, Janigan D, Raoult D. Route of infection determines the clinical manifestations of acute Q fever. J Infect Dis 1996; 173: 484-87.
79. Seshadri R, Paulsen IT, Eisen JA, et al. Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc Natl Acad Sci USA. 2003; 100: 5455-60.
80. Samuel JE, Kiss K, Varghees S. Molecular pathogenesis of Coxiella burnetii in a genomics era. Ann N Y Acad Sci 2003 Jun; 990: 653-63.
81. Andersson SG, Kurland CG. Reductive evolution of resident genomes. Trends Microbiol 1998; 6: 263-68.
82. 3 integrin and bacterial lipopolysaccharide are involved in Coxiella burnetii-stimulated production of tumor necrosis factor by human monocytes. Infect Immun 2000; 68: 5673-78.
83. Dellacasagrande J, Ghigo E, Raoult D, Capo C, Mege JL. IFN-gamma-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence. J Immunol 2002; 169: 6309-15.
84. Dellacasagrande J, Ghigo E, Capo C, Raoult D, Mege JL. Coxiella burnetii survives in monocytes from patients with Q fever endocarditis: involvement of tumor necrosis factor. Infect Immun 2000; 68: 160-64.
85. Ghigo E, Capo C, Tung CH, Raoult D, Gorvel JP, Mege JL. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing. J Immunol 2002; 169: 4488-95.
86. Harris RJ, Storm PA, Lloyd A, Arens M, Marmion BP. Long-term persistence of Coxiella burnetii in the host after primary Q fever. Epidemiol Infect 2000; 124: 543-49.
87. Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000; 79: 109-23.
88. Marrie TJ. Epidemiology of Q fever: acute Q fever. In: Marrie TJ ed. Q fever: the disease. Boca Raton: CRC Press, 1990: 49-70.
89. Marrie TJ. Epidemiology of Q fever: acute Q fever. In: Marrie TJ ed. Q fever: the disease. Boca Raton: CRC Press, 1990: 125-60.
90. Sawyer LA, Fishbein DB, McDade JE. Q fever: current concepts. Rev Infect Dis 1987; 9: 935-46.
91. Ackland JR, Worswick DA, Marmion BP. Vaccine prophylaxis of Q fever: a follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med J Aust 1994; 160: 704-08.
92. Dupont HL, Hornick RB, Levin HS, Rapoport MI, Woodward TE. Q fever hepatitis. Ann Intern Med 1971; 74: 198-206.
93. Hatchette TF, Marrie TJ. A typical manifestations of chronic Q fever. Clin Infect Dis 2001; 33: 1347-51.
94. Bernit E, Pouget J, Janbon F, et al. Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med 2002; 162: 693-700.
95. Bartlett JG. Questions about Q fever. Medicine (Baltimore) 2000; 79: 124-25.
96. Kambaratov AI, Il'inskii IuA, Batsina ZA, Kambaratova LA. Changes in the lungs in Q fever. Sov Med 1979; 4: 35-38.
97. Marrie TJ. A comparison of Q fever endocarditis with native valve endocarditis. Ann N Y Acad Sci 1990; 590: 61-67.
98. Raoult D, Etienne J, Massip P, et al. Q fever endocarditis in the south of France. J Infect Dis 1987; 155: 570-73.
99. Ayres JG, Flint N, Smith EG, et al. Post-infection fatigue syndrome following Q fever. QJM 1998; 91: 105-23.
100. Penttila IA, Harris RJ, Storm P, Haynes D, Worswick DA, Marmion BP. Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM 1998; 91: 549-60.
101. Ruiz-Contreras J, Gonzalez Montero R, Ramos Amador JT, Giancaspro Corradi E, Scarpellini Vera A. Q fever in children. Am J Dis Child 1993; 147: 300-02.
102. Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis 2002; 2: 686-91.
103. Levy P, Raoult D, Razongles JJ. Q-fever and autoimmunity. Eur J Epidemiol 1989; 5: 447-53.
104. Pickworth FE, el-Soussi M, Wells IP, McGavin CR, Reilly S. The radiological appearances of 'Q' fever pneumonia. Clin Radiol 1991; 44: 150-53.
105. Millar JK. The chest film findings in 'Q' fever: a series of 35 cases. Clin Radiol 1978; 29: 371-75.
106. Smith DL, Wellings R, Walker C, Ayres JG, Burge PS. The chest X ray in Q-fever: a report on 69 cases from the 1989 West Midlands outbreak. Br J Radiol 1991; 64: 1101-08.
107. Brown GL. Clinical aspects of 'Q' fever Postgrad Med J 1973; 49: 539-41.
108. Raoult D, Vestris G, Enea M. Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of the strains in HEL cells. J Clin Microbiol 1990; 28: 2482-84.
109. Ayres JG, Wildman M, Groves J, Ment J, Smith EG, Beattie JM. Long-term follow-up of patients from the 1989 Q fever outbreak: no evidence of excess cardiac disease in those with fatigue. QJM 2002; 95: 539-46.
110. Peter O, Dupuis G, Burgdorfer W, Peacock M. Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q fever. Eur J Clin Microbiol 1985; 4: 394-96.
111. Peter O, Flepp M, Bestetti G, Nicolet J, Luthy R, Dupuis G. Q fever endocarditis: diagnostic approaches and monitoring of therapeutic effects. Clin Invest 1992; 70: 932-37.
112. Cowley R, Fernandez F, Freemantle W, Rutter D. Enzyme immunoassay for Q fever: comparison with complement fixation and immunofluorescence tests and dot immunoblotting. J Clin Microbiol 1992; 30: 2451-55.
113. Tokarevich NK, Schramek S, Daiter AB. Indirect haemolysis test in Q-fever. Acta Virol 1990; 34: 358-60.
114. Kazar J, Brezina R, Schramek S, Palanova A, Tvrda B. Suitability of the microagglutination test for detection of post-infection and post-vaccination Q fever antibodies in human sera. Acta Virol 1981; 25: 235-40.
115. Doller G, Doller PC, Gerth HJ. Early diagnosis of Q fever: detection of immunoglobulin M by radioimmunoassay and enzyme immunoassay. Eur J Clin Microbiol 1984; 3: 550-53.
116. Blondeau JM, Williams JC, Marrie TJ. The immune response to phase I and phase II Coxiella burnetii antigens as measured by western immunoblotting. Ann N Y Acad Sci 1990; 590: 187-202.
117. Dupont HT, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol 1994; 1: 189-96.
118. Stein A, Raoult D. Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction. J Clin Microbiol 1992; 30: 2462-66.
119. Frazier ME, Heinzen RA, Mallavia LP, Baca OG. DNA probes for detecting Coxiella burnetii strains. Acta Virol 1992; 36: 83-89.
120. McDonald R, Cao T, Borschel R. Multiplexing for the detection of multiple biowarfare agents shows promise in the field. Mil Med 2001; 166:237-39.
121. Brouqui P, Dumler JS, Raoutt D. Immunohistologic demonstration of Coxiella burnetii in the valves of patients with Q fever endocarditis. Am J Med 1994; 97: 451-58.
122. McCaul TF, Williams JC. Localization of DNA in Coxiella burnetii by post-embedding immunoelectron microscopy. Ann N Y Acad Sci 1990; 590: 136-47.
123. Srigley JR, Vellend H, Palmer N, et al. Q-fever: the liver and bone marrow pathology. Am J Surg Pathol 1985; 9: 752-58.
124. Westlake P, Price LM, Russell M, Kelly JK. The pathology of Q fever hepatitis: a case diagnosed by liver biopsy. J Clin Gastroenterol 1987; 9: 357-63.
125. Qizilbash AH. The pathology of Q fever as seen on liver biopsy. Arch Pathol Lab Med 1983; 107: 364-67.
126. Raoult D. Treatment of Q fever. Antimicrob Agents Chemother 1993; 37: 1733-36.
127. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12: 518-53
128. Choi E. Tularemia and Q fever. Med Clin North Am 2002; 86: 393-416.
129. Perez-del-Molino A, Aguado JM, Riancho JA, Sampedro I, Matorras P, Gonzalez-Macias J. Erythromycin and the treatment of Coxiella burnetii pneumonia. J Antimicrob Chemother 1991; 28: 455-59.
130. Sobradillo V, Zalacain R, Capelastegui A, Uresandi F, Corral J. Antibiotic treatment in pneumonia due to Q fever. Thorax 1992; 47: 276-78.
131. Gikas A, Kofteridis, DP, Manios A, Pediaditis J, Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother 2001; 45: 3644-46.
132. Crespo M, Sopena B, Bordon J, de la Fuente J, Rubianes M, Martinez-Vazquez C. Steroids treatment of granulomatous hepatitis complicating Coxiella burnetii acute infection. Infection 1999; 27: 132-33.
133. Raoult D, Houpikian P, Tissot Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 1999; 159: 167-73.
134. Levy PY, Drancourt M, Etienne J, et al. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother 1991; 35: 533-37.
135. Calza L, Attard L, Manfredi R, Chiodo F. Doxycycline and chloroquine as treatment for chronic Q fever endocarditis. J Infect 2002; 45: 127-29.
136. Spyridaki I, Psaroulaki A, Kokkinakis E, Gikas A, Tselentis Y. Mechanisms of resistance to fluoroquinolones in Coxiella burnetii. J Antimicrob Chemother 2002; 49: 379-82.
137. Spyridaki I, Psaroulaki A, Aransay A, Scoulica E, Tselentis Y. Diagnosis of quinolone-resistant Coxiella burnetii strains by PCR-RFLP. J Clin Lab Anal 2000; 14: 59-63.
138. Salamand AC, Collart F, Caus T, et al. Q fever endocarditis: over 14 years of surgical experience in a referral center for rickettsioses. J Heart Valve Dis 2002; 11: 84-90.
139. Heard SR, Ronalds CJ, Heath RB. Coxiella burnetii infection in immunocompromised patients. J Infect 1985; 11: 15-18.
140. Montes M, Cilla G, Marimon JM, Diaz de Tuesta JL, Perez-Trallero E, Coxiella burnetii infection in subjects with HIV infection and HIV infection in patients with Q fever. Scand J Infect Dis 1995; 27: 344-46.
141. Marmion BP, Ormsbee RA, Kyrkou M, et al. Vaccine prophylaxis of abattoir-associated Q fever: eight years experience in Australian abattoirs. Epidemiol Infect 1990; 104: 275-87.
142. Marrie TJ. Coxiella burnetii (Q fever). In: Mandell GL, Douglas RG Jr, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone, 2000: 2043-50.
143. Marmion BP. Development of Q-fever vaccines, 1937 to 1967. Med J Aust 1967; 2: 1074-78.
144. Williams JC, Hoover TA, Waag DM, Banerjee-Bhatnagar N, Bolt CR, Scott GH. Antigenic structure of Coxiella burnetii: a comparison of lipopolysaccharide and protein antigens as vaccines against Q fever. Ann N Y Acad Sci 1990; 590: 370-80.
145. Wiener SL. Strategies for the prevention of a successful biological warfare aerosol attack. Mil Med 1996; 161: 251-56.
146. Centers for Disease Control and Prevention. Environmental infection control guidelines. MMWR Morb Mortal Wkly Rep (in press).
147. Farley JE. Q fever (Query fever). http://www.hopkins-heic.org/forum/q_fever.html (accessed Sept 21, 2003).
148. New York City Department of Health. Medical treatment and response to suspected Q fever: Information for health care providers during biologic emergencies. http://www.nyc.gov/html/doh/html/cd/qfmd.html (accessed Sept 21, 2003).
149. Division of Public Health Surveillance and Informatics. Nationally notifiable infectious diseases. http://www.cdc.gov/epo/dphsi/phs/infdis2003.htm (accessed Sept 21, 2003)